| scholarly article | Q13442814 |
| P2093 | author name string | Liang Zhang | |
| Jian Sun | |||
| Ya Ding | |||
| Shu Wu | |||
| Dongsheng Zhang | |||
| Su Li | |||
| Junling Liu | |||
| Zhongyu Yuan | |||
| Fangyong Lei | |||
| P2860 | cites work | De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling | Q24299573 |
| Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue | Q77372895 | ||
| Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation | Q24309469 | ||
| Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes | Q24312187 | ||
| Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling | Q24337661 | ||
| Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity | Q24530708 | ||
| Treatment of gastric cancer | Q24602875 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Identification of the familial cylindromatosis tumour-suppressor gene | Q28145560 | ||
| CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members | Q28201693 | ||
| The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination | Q28201717 | ||
| Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity | Q28276063 | ||
| Shaping the nuclear action of NF-kappaB | Q29614600 | ||
| Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B | Q29618210 | ||
| Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO | Q29618712 | ||
| Epidemiology of gastric cancer | Q33788193 | ||
| The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. | Q34235332 | ||
| Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway | Q34444831 | ||
| NF-kappaB as a therapeutic target in cancer | Q34750172 | ||
| International variation | Q35868021 | ||
| miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops. | Q36596742 | ||
| Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcino | Q36947423 | ||
| NF-kappaB and cancer-identifying targets and mechanisms | Q36984251 | ||
| Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma | Q37061845 | ||
| CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes | Q37448141 | ||
| The role of the kinases RIP1 and RIP3 in TNF-induced necrosis | Q37721675 | ||
| Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma | Q37723277 | ||
| Deubiquitinases in the regulation of NF-κB signaling | Q37814068 | ||
| Expanding role of ubiquitination in NF-κB signaling | Q37816941 | ||
| First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. | Q39393075 | ||
| Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression. | Q39721819 | ||
| Reduced expression of CYLD in human colon and hepatocellular carcinomas | Q40267883 | ||
| NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling | Q46820406 | ||
| Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. | Q53618136 | ||
| Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer. | Q54305213 | ||
| Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation | Q57372470 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 2483-2495 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis | |
| P478 | volume | 6 |
| Q26780293 | Dysregulation of non-coding RNAs in gastric cancer |
| Q92669327 | High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation |
| Q35927721 | Identification of a blood-borne miRNA signature of synovial sarcoma |
| Q38699763 | Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer |
| Q38751308 | MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway |
| Q36413197 | MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer |
| Q50122609 | MicroRNA‑1288 promotes cell proliferation of human glioblastoma cells by repressing ubiquitin carboxyl‑terminal hydrolase CYLD expression |
| Q39204794 | NF-κB Signaling in Gastric Cancer. |
| Q51664715 | Noncoding RNAs Regulating NF-κB Signaling. |
| Q38824331 | Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women |
| Q90448135 | Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules |
| Q39237748 | Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis |
| Q41548169 | Prognostic value of microRNAs in gastric cancer: a meta-analysis |
| Q42367776 | The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity |
| Q61797524 | The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer |
| Q64070295 | miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer |
| Q44501687 | miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survival |
Search more.